Lamotrigine Pregnancy Registry

Please note that this registry is now CLOSED.

The Lamotrigine Pregnancy Registry has met its enrolment goal and, as such, the Lamotrigine Pregnancy Registry Advisory Committee and GlaxoSmithKline closed the Registry on 31 March 2010.

A Final Report will be issued in July 2010.

We wish to thank everyone for their support of the Registry which enabled the Registry to achieve its goals. Your efforts in sending us registrations, follow-up information, and additional targeted follow-up information have been integral to the success of the Registry!

For questions related to Lamotrigine exposure during pregnancy or other questions, please contact GlaxoSmithKline’s Response Center at 1-888-825-5249. Patients can still enroll themselves into the North American AED Pregnancy Registry by calling 1-888-233-2334 (toll-free).

Final Report for Lamotrigine - issued 2010 (PDF format)

Additional resources: